GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ansell Ltd (OTCPK:ANSLF) » Definitions » Altman Z-Score

Ansell (Ansell) Altman Z-Score : 3.25 (As of May. 05, 2024)


View and export this data going back to . Start your Free Trial

What is Ansell Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 3.28 is strong.

Ansell has a Altman Z-Score of 3.25, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Ansell's Altman Z-Score or its related term are showing as below:

ANSLF' s Altman Z-Score Range Over the Past 10 Years
Min: 2.38   Med: 3.12   Max: 4.03
Current: 3.28

During the past 13 years, Ansell's highest Altman Z-Score was 4.03. The lowest was 2.38. And the median was 3.12.


Ansell Altman Z-Score Historical Data

The historical data trend for Ansell's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ansell Altman Z-Score Chart

Ansell Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.08 3.50 4.03 3.15 3.21

Ansell Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.15 - 3.21 -

Competitive Comparison of Ansell's Altman Z-Score

For the Medical Instruments & Supplies subindustry, Ansell's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ansell's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Ansell's Altman Z-Score falls into.



Ansell Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Ansell's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.1966+1.4*0.4057+3.3*0.0819+0.6*2.533+1.0*0.654
=3.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Jun. 2023:
Total Assets was $2,531 Mil.
Total Current Assets was $912 Mil.
Total Current Liabilities was $415 Mil.
Retained Earnings was $1,027 Mil.
Pre-Tax Income was $190 Mil.
Interest Expense was $-18 Mil.
Revenue was $1,655 Mil.
Market Cap (Today) was $2,318 Mil.
Total Liabilities was $915 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(912 - 414.6)/2530.6
=0.1966

X2=Retained Earnings/Total Assets
=1026.6/2530.6
=0.4057

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(189.6 - -17.6)/2530.6
=0.0819

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=2318.179/915.2
=2.533

X5=Revenue/Total Assets
=1655.1/2530.6
=0.654

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Ansell has a Altman Z-Score of 3.25 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Ansell  (OTCPK:ANSLF) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Ansell Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Ansell's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Ansell (Ansell) Business Description

Traded in Other Exchanges
Address
678 Victoria Street, Level 3, Richmond, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.

Ansell (Ansell) Headlines

From GuruFocus

Ansell Growing Through M&A

By Holmes Osborne, CFA Holmes Osborne, CFA 02-22-2019

Australian Ansell Expanding Into Medical Supplies

By Holmes Osborne, CFA Holmes Osborne, CFA 02-15-2017

PPE Manufacturer Ansell Still Trading at a Nice Valuation

By Holmes Osborne, CFA Holmes Osborne, CFA 05-19-2021